UTHR7:30 AMUnited Therapeutics Corporation Announces ADVANCE OUTCOMES Study of Ralinepag Published in The LancetTrial Results • Phase 3unither.com
UTHR7:30 AMUnited Therapeutics Corporation Announces Appointment of Victor Dzau to its Board of Directorsunither.com
UTHR8:00 AMUnited Therapeutics Corporation to Report Second Quarter 2026 Financial Results Before Market Open on Wednesday, August 5, 2026unither.com
UTHR7:30 AMUnited Therapeutics Corporation Announces FDA Approval of the LungFX™ Device for Centralized Ex Vivo Lung Perfusionunither.com
UTHR8:00 AMUnited Therapeutics Corporation to Present at the Jefferies Global Healthcare Conferenceunither.com
UTHR5:15 PMUnited Therapeutics Corporation Announces TETON-1 Study of Tyvaso Published in The New England Journal of Medicine and Presented at ATS 2026Trial Results • Phase 3ATS Breaking News session Sun, May 17, 2026unither.com